期刊文献+

抗人血管内皮生长因子发夹状核酶对人脐静脉内皮细胞ECV304的影响 被引量:1

Effect of Anti-VEGF Hairpin Ribozyme on ECV304 Cells
下载PDF
导出
摘要 目的观察抗人血管内皮生长因子(VEGF)发夹状核酶对人脐静脉内皮细胞ECV304生物学特性的影响。方法将抗人VEGF发夹状核酶(RZ)基因构建的pcDNA3.1+/RZ转染ECV304细胞,经G418筛选后,用RT-PCR法鉴定RZ基因在ECV304细胞中的转录,用MTT法和流式细胞仪检测转染前后ECV304细胞增殖活力和细胞周期,ELISA法检测细胞上清VEGF的表达水平。结果RZ基因在ECV304细胞中获得转录,它不改变细胞增殖活力和细胞周期,但能明显下调VEGF的表达。结论抗人VEGF发夹状核酶能够显著抑制ECV304细胞VEGF的表达,为进一步开展核酶的肿瘤基因治疗提供了实验依据。 Objective To observe the biological effects of anti-VEGF hairpin ribozyme(RZ) on ECV304 cells. Methods The plasmid pcDNA3.1 + constructed by anti-VEGF RZ was transfected into ECV304 cells and the positive clones were screened by G418. The ribozyme gene transcription in ECV304 cells was confirmed by RT-PCR. The proliferation activity and cell cycle of ECV304 cells before and after transfection was inspected by MTT assay and FCAS. Then the VEGF expression was determined by ELISA assay. Results The ribozyme gene can be transcribed successfully in ECV304 cells, which can not change proliferation activity and cell cycle of ECV304 cells, but it can decrease the level of VEGF expression. Conclusion Anti-VEGF hairpin ribozyme gene can inhibit the VEGF expression of ECV304 cells in vitro. This study provided an experimental evidence for further tumor gene therapy of ribozyme.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2007年第4期524-526,共3页 Suzhou University Journal of Medical Science
关键词 血管内皮生长因子 核酶 ECV304 VEGF ribozyme ECV304
  • 相关文献

参考文献9

  • 1Yano S,Matsumori Y,Ikuta K,et al.Current status and perspective of angiogenesis and antivascular therapeutic strategy:non-small cell lung cancer[J].Int J Clin Oncol,2006,11(2):73-81.
  • 2Jimenez JA,Kao C,Raikwar S,et al.Current status of anti-angiogenesis therapy for prostate cancer[J].Urol Oncol,2006 24(3):260-268.
  • 3Nor JE,Ch ristensen J,Mooney DJ,et al.Vascular endothelial growth factor (VEGF) mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression[J].Am J Pathol,1999,154(2):375-384.
  • 4Mathur SP,Mathur RS,Gray EA,et al.Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer:Relationship to insulin-like growth factor Ⅱ (IGF-Ⅱ),IGF binding protein 3 (IGF-BP3) and VEGF-A[corrected][J].Gynecol Oncol,2005 98(3):467-483.
  • 5Gerwins P,Skoldenberg E,Claesson Welsh L.Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis[J].Crit Rev Oncol Hematol,2000,34(3):185-194.
  • 6Schrader AJ,Varga Z,Pfoertner S,et al.Treatment targeted at vascular endothelial growth factor:a promising approach to managing metastatic kidney cancer[J].BJU Int,2006,97(3):461-465.
  • 7Oshika Y,Nakam ura M,Tokunaga T,et al.Ribozyme approach to downregulate vascular endothelial growth factor 189 expression in non-small cell lung cancer NSCLC[J].Eur J Cancer,2000,36(18):2390-2396.
  • 8黄世杰.vardenafil[J].国外医学(药学分册),2003,30(2):124-125. 被引量:114
  • 9严玲玲,郭子健,杨吉成,李莉华,黄朝晖,谢宇锋,盛伟华.抗人VEGF发卡状核酶对肝癌细胞SMMC-7721生物学特性的影响[J].中华实验外科杂志,2005,22(11):1303-1303. 被引量:2

二级参考文献1

  • 1Oshika Y,Nakamura M,Tokunaga T,et al.Ribozyme approach to downregulate vascular endothelial growth factor 189 expression in non-small cell lung cancer NSCLC.Eur J Cancer,2000,36:2390-2396.

共引文献114

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部